Vertex Pharmaceuticals· @VertexPharma · X·· 2025-12-06AI 评分42
AI 导读
我们很高兴在本周末第67届ASH年会上分享我们针对镰状细胞病和输血依赖性β地中海贫血的基因编辑疗法多项研究的新数据。了解更多：https://news.vrtx.com/news-releases/news-release-details/vertex-presents-new-data-casgevyr-including-first-ever-data #ASH25
正文
We are pleased to share new data from multiple studies of our gene-edited therapy for sickle cell disease and transfusion-dependent beta thalassemia at the 67th ASH Annual Meeting this weekend. Learn more: https://news.vrtx.com/news-releases/news-release-details/vertex-presents-new-data-casgevyr-including-first-ever-data #ASH25
来源：Vertex Pharmaceuticals · x.com